ASCL1 Activators include compounds that can indirectly influence the expression or activity of ASCL1. These chemicals operate by modulating various signaling pathways or cellular processes that are known to regulate the levels of ASCL1 or its transcriptional activity. The mechanisms by which these compounds act are diverse, involving different cellular signaling cascades and regulatory molecules. The common objective of these chemicals is to either enhance the signaling pathways that lead to an increase in ASCL1 expression or to create a cellular environment that is conducive to ASCL1 activity.
Compounds like EGF and Isoproterenol function by activating specific receptors on the cell surface, leading to a cascade of intracellular events that culminate in the upregulation of ASCL1. Others, such as Retinoic acid and Forskolin, exert their effects by interacting with intracellular signaling molecules or enzymes, thereby influencing gene expression patterns that include ASCL1. Histone deacetylase inhibitors like Sodium Butyrate and Valproic Acid alter the chromatin state, leading to increased transcription of ASCL1. The variation in mechanisms underscores the complexity of modulating transcription factor activity indirectly, as each pathway can converge on ASCL1 from different regulatory points within the cell. The activation of ASCL1 by these compounds relies on the intricate balance of signaling pathways that govern its expression. The modulation of PKA activity by cAMP analogs, the inhibition of GSK-3β to activate Wnt signaling, and the direct effect on chromatin structure by histone deacetylase inhibitors all represent strategies that can culminate in increased ASCL1 levels. The direct activation of transcription factors such as ASCL1 is rare, making the identification and use of indirect activators a necessary approach. These indirect activators may not only upregulate ASCL1 but also affect a broad spectrum of cellular functions due to their wide-ranging effects on signaling pathways and gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through its receptors and has been shown to upregulate ASCL1 during neurogenesis. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that can permeate cell membranes and activate PKA, potentially leading to an increase in ASCL1 expression by enhancing CREB activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that increases cAMP levels, potentially enhancing ASCL1 expression through PKA activation and CREB phosphorylation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP and activating PKA. PKA activation can lead to the phosphorylation of proteins that may increase ASCL1 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which can modulate numerous pathways, potentially leading to an increase in ASCL1 through mechanisms like CREB phosphorylation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, leading to Wnt pathway activation, which has been implicated in increasing ASCL1 expression in certain contexts. | ||||||
Potassium Chloride | 7447-40-7 | sc-203207 sc-203207A sc-203207B sc-203207C | 500 g 2 kg 5 kg 10 kg | $55.00 $155.00 $285.00 $455.00 | 5 | |
Elevating extracellular potassium levels can lead to depolarization-induced signaling cascades that increase ASCL1 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can lead to a more relaxed chromatin structure around the ASCL1 gene, potentially increasing its expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Another histone deacetylase inhibitor that could increase ASCL1 expression through chromatin remodeling. | ||||||